HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING—
Price Investing Group
← Back to Research Watchlist
NEOG
Neogen Corp
Healthcare Diagnostics & Research · Michigan, USA · Reports in usd
—
Market Cap: $2.62B
Market Cap
$2.62B
Enterprise Val
$3.22B
P/E Ratio
-46.62
P/B Ratio
1.25
Trailing PEG (1Y)
0.36
As Of
Oct 11, 2026

Overview & Key Metrics

Reporting period: Aug 31, 2026 · Q1 2027
Book Value$2.09B
Gross Margin47.35%
Profit Margin47.35%
Return on Equity-2.68%
Return on Assets-1.68%
Current Ratio3.90
Debt/Equity0.37
LT Debt/Equity0.37
Revenue Per Share1.02

Income Statement

Aug 31, 2026
Revenue$222.8M
Cost of Revenue$117.3M
Gross Profit$105.5M
R&D$6.5M
SG&A$100.8M
Operating Expenses$107.3M
Operating Income-$1.8M
Interest Expense$13.8M
Tax Expense-$3.0M
Net Income-$11.9M
EPS (Basic)$-0.05
EPS (Diluted)$-0.05
EBIT-$1.1M
EBITDA$29.3M
Consolidated Income-$11.9M
Non-Controlling Interests$0.00

Balance Sheet

Aug 31, 2026
Cash & Equivalents$172.0M
Accounts Receivable$136.2M
Inventory$146.1M
Current Assets$582.5M
LT Investments$0.00
Property, Plant & Equipment$348.9M
Intangibles$2.34B
Non-Current Assets$2.72B
Total Assets$3.30B
Accounts Payable$77.6M
Current Debt$0.00
Current Liabilities$149.5M
LT Debt$774.2M
Non-Current Liabilities$1.07B
Total Liabilities$1.22B
Total Debt$774.2M
Retained Earnings-$556.2M
Shareholder Equity$2.09B
Shares Outstanding218,056,016

Cash Flow Statement

Aug 31, 2026
Operating Cash Flow$12.9M
Investing Cash Flow-$8.2M
Financing Cash Flow-$19.0M
CapEx-$8.2M
Free Cash Flow$4.7M
Depreciation & Amort.$30.4M
Stock-Based Comp$3.1M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$20.0M
Equity Issued/Repaid$2.2M
Dividends Paid$0.00
Net Change in Cash-$13.5M
Data cached · Meta live · Daily live · Statements live · TTL 24h